Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 9 studies | 76% ± 20% | |
retinal rod cell | 9 studies | 60% ± 21% | |
GABAergic neuron | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 7 studies | 38% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 67.87 | 176 / 180 | 52% | 8.26 | 224 / 430 |
adrenal gland | 96% | 48.21 | 248 / 258 | 16% | 0.56 | 37 / 230 |
bladder | 100% | 41.90 | 21 / 21 | 1% | 0.02 | 5 / 504 |
uterus | 98% | 69.98 | 166 / 170 | 3% | 0.34 | 14 / 459 |
spleen | 100% | 88.10 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 99% | 62.03 | 955 / 966 | 0% | 0.00 | 1 / 527 |
breast | 98% | 49.22 | 450 / 459 | 1% | 0.01 | 10 / 1118 |
blood vessel | 99% | 61.91 | 1319 / 1335 | 0% | 0 | 0 / 0 |
kidney | 98% | 52.45 | 87 / 89 | 1% | 0.02 | 9 / 901 |
brain | 96% | 41.35 | 2541 / 2642 | 2% | 0.03 | 15 / 705 |
prostate | 98% | 42.62 | 239 / 245 | 0% | 0.00 | 1 / 502 |
thymus | 98% | 38.78 | 638 / 653 | 0% | 0 | 0 / 605 |
adipose | 98% | 45.83 | 1175 / 1204 | 0% | 0 | 0 / 0 |
stomach | 96% | 70.83 | 345 / 359 | 1% | 0.02 | 3 / 286 |
esophagus | 97% | 51.52 | 1396 / 1445 | 0% | 0 | 0 / 183 |
lung | 95% | 44.02 | 550 / 578 | 1% | 0.02 | 12 / 1155 |
skin | 94% | 35.16 | 1697 / 1809 | 0% | 0.01 | 2 / 472 |
heart | 92% | 35.37 | 788 / 861 | 0% | 0 | 0 / 0 |
pancreas | 90% | 24.69 | 296 / 328 | 1% | 0.02 | 2 / 178 |
muscle | 90% | 30.84 | 723 / 803 | 0% | 0 | 0 / 0 |
liver | 82% | 20.15 | 186 / 226 | 0% | 0.00 | 1 / 406 |
peripheral blood | 70% | 27.84 | 652 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 2.39 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0008104 | Biological process | protein localization |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0060042 | Biological process | retina morphogenesis in camera-type eye |
GO_0042995 | Cellular component | cell projection |
GO_0033165 | Cellular component | interphotoreceptor matrix |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0016020 | Cellular component | membrane |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0008201 | Molecular function | heparin binding |
GO_0005540 | Molecular function | hyaluronic acid binding |
Gene name | IMPG2 |
Protein name | Interphotoreceptor matrix proteoglycan 2 Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan) Interphotoreceptor matrix proteoglycan IPM 200 |
Synonyms | IPM200 |
Description | FUNCTION: Chondroitin sulfate- and hyaluronan-binding proteoglycan involved in the organization of interphotoreceptor matrix; may participate in the maturation and maintenance of the light-sensitive photoreceptor outer segment. Binds heparin. . |
Accessions | ENST00000193391.8 Q9BZV3 F1T0J3 Q96RP4 |